Health Care & Life Sciences » Pharmaceuticals » Amgen | Amgen R&D expenditure 2006-2017

Amgen's expenditure on research and development 2006-2017

Amgen's expenditure on research and development from 2006 to 2017 (Figures expressed in millions of U.S. dollars, unless otherwise specified)

The data displays the expenditure on research and development of biotech company Amgen from 2004 to 2017. Amgen is a U.S.-based multinational biopharmaceutical company, headquartered in Thousand Oaks, California. Amgen's R&D expenses amounted to approx. 3.6 billion USD in 2017.

2006	3366
2007	3266
2008	3030
2009	2864
2010	2894
2011	3167
2012	3380
2013	4083
2014	4297
2015	4070
2016	3840
2017	3562

Amgen's expenditure on research and development 2006-2017

StatInvestor